Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN33897799
ISRCTN33897799
Completed
Not Applicable

Moderate functional ischemic mitral regurgitation patients randomised to Coronary Artery Bypass Graft (CABG) versus CABG and down-sized ring annuloplasty

Montreal Heart Institute (Canada)0 sites58 target enrollmentJune 28, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsFunctional ischemic mitral regurgitationCirculatory SystemMitral (valve) insufficiency

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Functional ischemic mitral regurgitation
Sponsor
Montreal Heart Institute (Canada)
Enrollment
58
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 28, 2011
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Montreal Heart Institute (Canada)

Eligibility Criteria

Inclusion Criteria

  • •Moderate (grade 2\+) functional ischemic mitral regurgitation in patients undergoing coronary artery bypass grafing

Exclusion Criteria

  • •1\. Papillary muscle rupture
  • •2\. Concomitant aortic valve surgery
  • •3\. Life expectancy less than 12 months
  • •4\. Creatinine \> 200 µmol/l

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
moderate ischemic mitral regurgeCardiologyCirculatory Systemmitral valve disease
PACTR201710002640828menoufia university40
Not yet recruiting
Not Applicable
To study the improvement of ischemic moderate mitral regurgitation after coronary artery bypass grafting only and not mitral valve replacement.Health Condition 1: I340- Nonrheumatic mitral (valve) insufficiency
CTRI/2022/05/042900fortis escorts heart institute
Active, not recruiting
Phase 4
High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: a Randomized Controlled Trial Comparing MitraClip® to Surgical TherapyDegenerative Mitral RegurgitationI34.0Mitral (valve) insufficiency
DRKS00008923Klinikdirektor, Klinik für Herz- und Gefäßchirurgie5
Completed
Not Applicable
ong term cardiac monitoring in mitral valve prolapseMitral valve prolapseArrhythmiasCardiovascular - Other cardiovascular diseases
ACTRN12619001159145Han S. Lim21
Recruiting
Not Applicable
Coagubility in severe mitral regurgitation: A within-patient evaluation of coagulation status before and after Mitral Valve Transcatheter Edge-to-Edge Repair.
NL-OMON56294Sint Antonius Ziekenhuis50